Nucleic Acid Testing Reagent Listed Companies Gross Profit Ranking (Q3 2022 List)

Trend stock picking system financial report tool data collated, as of the third quarter of 2022, nucleic acid testing reagents listed companies gross profit rankings, Liju Group ranked first, with a gross profit of 2.105 billion yuan; Daan Gene ranked second, with a gross profit of 1.885 billion yuan; Dean Diagnostics ranked third, with a gross profit of 1.78 billion yuan. Ranked in the top 10 of the other:Mind Biology, Watson Biological, Kepu Biological, Shengxiang Biological, Runda Medical, UW Genetics, Shuoshi Biological.

NO.1, Li Zhu Group:2.105 billion yuan

Company Location:Guangdong

Industry:Pharmaceutical Manufacturing

The company realized total revenue of 3.186 billion yuan in the third quarter of 2022, a year-on-year increase of 1.66%; gross profit of 2.105 billion yuan, gross profit margin of 66.08%.

NO.2, Daan Gene: 1.885 billion yuan

Company Location: Guangdong

Industry: Medical Device

Daan Gene 2022 third quarterly report shows that the company achieved total revenue of 2.66 billion yuan, an increase of 23.46%; gross profit of 1.885 billion yuan. Gross profit margin of 70.89%.

NO.3, Dean Diagnostics: 1.78 billion yuan

Company Location: Zhejiang

Industry: Medical Services

Dean Diagnostics 2022 third quarterly report shows that the company achieved total operating income of 4.876 billion yuan, an increase of 37.48%; to achieve gross profit of 1.78 billion yuan, gross profit margin of 36.5%.

NO.4, Mindray Bio:1.536 billion yuan

Company Location:Hubei

Industry:Medical Devices

The company's Q3 2022 quarterly report shows that the third quarter of 2022 to achieve a total revenue of 2.217 billion yuan, an increase of 178.14% year-on-year; to achieve gross profit of 1.536 billion yuan with a gross profit margin of 69.29%.

NO.5, Watson Biological:1.217 billion yuan

Company Location:Yunnan

Industry:Biological Products

The company realized total revenue of 1.358 billion in the third quarter of 2022, an increase of 74.24% year-on-year; to achieve a gross profit of 1.217 billion yuan, gross profit margin of 89.58%.

NO.6, Kemper Bio: 956 million yuan

Company Location: Guangdong

Industry: Medical Devices

Kemper Bio, Inc. in the third quarter of 2022 to achieve total revenue of 1.416 billion, an increase of 104.33% year-on-year growth; gross profit of 956 million yuan, gross profit margin of 67.49%.

NO.7, Shengxiang Biological:802 million yuan

Company Location:Hunan

Industry:Medical Devices

The company's quarterly report for the third quarter of 2022, the third quarter of 2022 to achieve total revenue of 1.378 billion, an increase of 11.25% year-on-year growth; to achieve gross profit of 802 million, gross profit margin of 58.21%. Gross profit margin of 58.21%.

NO.8, Runda Medical:798 million yuan

Company Location:Shanghai

Industry:Medical Services

Runda Medical third quarter of 2022, the company achieved total revenue of 2.873 billion, an increase of 19.88% year-on-year growth; gross profit of 798 million yuan, a gross profit margin of 27.76%.

NO.9, UW Genetics:767 million yuan

Company Location:Guangdong

Industry:Medical Device

In the third quarter of 2022, UW Genetics realized total revenue of 1.353 billion, an increase of -10.17% year-on-year; gross profit of 767 million yuan, a gross profit margin of 56.73%.

NO.10, Shuo Shi Biological:632 million yuan

Company Location:Jiangsu

Industry:Medical Device

The company realized total revenue of 1.028 billion in the third quarter of 2022, an increase of -1.32% year-on-year growth; gross profit of 632 million yuan, gross profit margin of 61.52%.

All the information content of the South wealth network does not constitute investment advice, the stock market is risky, investment should be cautious.